接种量与突变频率对肠杆菌科磷霉素琼脂稀释与肉汤微量稀释MIC差异的影响
该研究比较了220株临床分离的大肠埃希菌和肺炎克雷伯菌在CLSI推荐的琼脂稀释法与肉汤微量稀释法下的磷霉素MIC差异,发现微量稀释法所用初始接种量更高(5.63倍),且可富集耐药亚群,部分解释MIC差异。
要点
- 磷霉素MIC在两种方法间存在差异,肺炎克雷伯菌分类一致率仅51.1%。
- 微量稀释法初始接种量是琼脂稀释法的5.63倍,与CLSI方法范围一致。
- 耐药亚群主要在接种量>3.13×10^4 CFU/孔孵育8小时后出现。
核心结论
- 微量稀释法较高的接种量富集了耐药亚群,可部分解释磷霉素MIC与琼脂稀释法的差异。
研究设计与样本
- 对220株临床分离株(大肠埃希菌81株,肺炎克雷伯菌139株)用琼脂稀释法(参考)和肉汤微量稀释法测定磷霉素MIC。
- 在21株大肠埃希菌(MIC=1mg/L)和21株肺炎克雷伯菌(MIC=16mg/L)中测定磷霉素突变频率。
- 对5株大肠埃希菌(MIC=1mg/L)用0、4、8mg/L磷霉素和8种接种量(5×10^5至3.91×10^3 CFU/孔,1:2稀释)监测耐药亚群出现。
主要发现
- 大肠埃希菌:分类一致率86.4%,极重大误差9.1%,重大误差3.3%,次要误差9.9%。
- 肺炎克雷伯菌:分类一致率51.1%,极重大误差15.7%,重大误差28.4%,次要误差25.2%。
- 基本一致率(±1个倍比稀释)为55.45%;微量稀释法35.9%的MIC差异≥2个稀释度。
- 微量稀释法初始接种量是琼脂稀释法的5.63倍。
- 大肠埃希菌突变频率为6.05×10^-5(4×MIC)至5.59×10^-7(256×MIC),肺炎克雷伯菌为1.49×10^-4(4×MIC)至1.58×10^-5(16×MIC)。
临床怎么用
- 解读磷霉素药敏结果时需考虑方法学差异,尤其是肺炎克雷伯菌的微量稀释法结果。
- 临床微生物实验室应关注接种量对磷霉素MIC的影响,必要时按CLSI规范操作并谨慎报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Fosfomycin is re-evaluated as a treatment of multidrug-resistant Enterobacteriaceae infections. However, MIC differences have been described among the different susceptibility testing. The aim was to study the role of the different inoculum size used in agar dilution with respect to broth microdilution, according to CLSI, in the fosfomycin MIC discrepancies. METHODS: Fosfomycin MICs were determined using agar dilution (reference) and broth microdilution in 220 Escherichia coli (n=81) and Klebsiella pneumoniae (n=139) clinical isolates. Fosfomycin mutant frequencies were determined in 21 E. coli (MIC=1mg/L) and 21 K. pneumoniae (MIC=16mg/L). The emergence of resistant subpopulations of five E. coli strains (MIC=1mg/L) was monitored over the time by microdilution assay using 0, 4 and 8 mg/L of fosfomycin, and eight different inocula (5×105-3.91×103 CFU/well, 1 : 2 dilutions). RESULTS: For E. coli, 86.4% of categorical agreement (CA), 9.1% very major errors (VME), 3.3% major errors (ME) and 9.9% minor errors (mE) were found. For K. pneumoniae, CA was 51.1%, VME 15.7%, ME 28.4% and mE 25.2%. Essential agreement (±1-log2) was observed in 55.45%. By microdilution, 35.9% of the MICs showed discrepancies of ≥2 dilutions. Initial inoculum used was 5.63 times higher in the microdilution method, in range with CLSI methodology for both techniques. Fosfomycin mutant frequencies were 6.05×10-5 (4×MIC) to 5.59×10-7 (256×MIC) for E. coli, and 1.49×10-4 (4×MIC) to 1.58×10-5 (16×MIC) for K. pneumoniae. Resistant subpopulations arose mainly after 8 h of incubation with inocula >3.13×104 CFU/well. CONCLUSIONS: The higher inoculum used in the microdilution method enriched the initial inoculum with resistant subpopulations and could partially explain the fosfomycin MIC discrepancies with respect to the agar dilution method.
引用
- Ballestero-Téllez M, Docobo-Pérez F, Rodríguez-Martínez JM, et al. Role of inoculum and mutant frequency on fosfomycin MIC discrepancies by agar dilution and broth microdilution methods in Enterobacteriaceae. Clin Microbiol Infect. 2017. PMID: 28062317. doi:10.1016/j.cmi.2016.12.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。